Clinical Improvement After Treatment With IncobotulinumtoxinA (XEOMIN®) in Patients With Cervical Dystonia Resistant to Botulinum Toxin Preparations Containing Complexing Proteins

This study investigated the clinical long-term effect of incobotulinumtoxinA (incoBoNT/A) in 33 cervical dystonia (CD) patients who had developed partial secondary therapy failure (PSTF) under previous long-term botulinum toxin (BoNT) treatment. Patients were treated four times every 12 weeks with i...

Descripción completa

Detalles Bibliográficos
Autores principales: Hefter, Harald, Hartmann, Christian J., Kahlen, Ulrike, Samadzadeh, Sara, Rosenthal, Dietmar, Moll, Marek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7900567/
https://www.ncbi.nlm.nih.gov/pubmed/33633680
http://dx.doi.org/10.3389/fneur.2021.636590

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7900567/
https://www.ncbi.nlm.nih.gov/pubmed/33633680
http://dx.doi.org/10.3389/fneur.2021.636590

Ejemplares similares